Imunon, Inc. Proceeds from Issuance or Sale of Equity
Imunon, Inc. (IMNN) reported Proceeds from Issuance or Sale of Equity of $15.00 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2021-05-14
- Imunon, Inc. proceeds from issuance or sale of equity for the quarter ending 2021-03-31 was $15.00M.
- Imunon, Inc. proceeds from issuance or sale of equity for the quarter ending 2013-09-30 was $0.00.
- Imunon, Inc. proceeds from issuance or sale of equity for the quarter ending 2013-06-30 was $400.00K.
- Imunon, Inc. proceeds from issuance or sale of equity for the quarter ending 2013-03-31 was $0.40.
- Imunon, Inc. proceeds from issuance or sale of equity for fiscal 2020 was $43.00M.
| Period end | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $15.00M 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | $43.00M 10-K · filed 2021-03-19 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $400.00K derived: sum of 2 quarters · filed 2013-11-12 | $400.00K 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $400.00K 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $0.40 10-Q · filed 2013-05-09 | ||||
| 2013-02-26 | $15.00M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |